Narnatumab Uses, Dosage, Side Effects and more
Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).
| Trade Name | Narnatumab |
| Generic | Narnatumab |
| Narnatumab Other Names | Narnatumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
